We used thalidomide to treat 10 patients with advanced stage multiple myeloma who had failed to obtain at least a partial response after a VAD-based induction therapy. Seven out 10 cases achieved clinical and histologic responses and proceeded to collection of peripheral blood stem cells and transplantation and ASCT.

Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients

PATRIARCA, Francesca;ZAJA, Francesco;FANIN, Renato
2003

Abstract

We used thalidomide to treat 10 patients with advanced stage multiple myeloma who had failed to obtain at least a partial response after a VAD-based induction therapy. Seven out 10 cases achieved clinical and histologic responses and proceeded to collection of peripheral blood stem cells and transplantation and ASCT.
File in questo prodotto:
File Dimensione Formato  
Patriarca Haematologica 2003.pdf

non disponibili

Tipologia: Altro materiale allegato
Licenza: Non pubblico
Dimensione 131.31 kB
Formato Adobe PDF
131.31 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/735955
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact